Company

Evopoint Biosciences' Imipenem/Cilastatin/Funobactam Wins NMPA Marketing Approval – Class 1 Triple‑Combination Antibiotic for HABP and VABP
Evopoint BiosciencesProduct approvals

Evopoint Biosciences’ Imipenem/Cilastatin/Funobactam Wins NMPA Marketing Approval – Class 1 Triple‑Combination Antibiotic for HABP and VABP

Evopoint Biosciences (SHA: 688837) announced that its Class 1 innovative drug, Imipenem, Cilastatin and Funobactam for Injection (IMI/FUN), has been approved for marketing by China's National Medical Products Administration (NMPA).…

Eli Lilly's Foundayo (Orforglipron) Wins NMPA Approval – First Oral GLP‑1 Receptor Agonist for Adult Weight Management in China

Eli Lilly’s Foundayo (Orforglipron) Wins NMPA Approval – First Oral GLP‑1 Receptor Agonist for Adult Weight Management in China

Fuzhou Luyan Pharmacy Secures Exclusive Greater China Rights to French Synergia Brand in Strategic Partnership with Curae LAB

Fuzhou Luyan Pharmacy Secures Exclusive Greater China Rights to French Synergia Brand in Strategic Partnership with Curae LAB

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
Bayer AG Initiates Phase I Study Combining BAY3498264 with Sotorasib for KRAS-Mutated Tumors
BayerCancer

Bayer AG Initiates Phase I Study Combining BAY3498264 with Sotorasib for KRAS-Mutated Tumors

CureGene Pharmaceutical Gets NMPA Approval for Antiplatelet Drug CG-0255
Clinical trial approval / initiationCureGene Pharmaceutical

CureGene Pharmaceutical Gets NMPA Approval for Antiplatelet Drug CG-0255

Johnson & Johnson MedTech's Impella Heart Pumps Gain FDA Approval for Pediatric Heart Failure
AbiomedCVD

Johnson & Johnson MedTech’s Impella Heart Pumps Gain FDA Approval for Pediatric Heart Failure

Pfizer's Ibrance Demonstrates Significant PFS Improvement in Phase III PATINA Trial
CancerClinical trial results

Pfizer’s Ibrance Demonstrates Significant PFS Improvement in Phase III PATINA Trial

Show More